Research ArticleClinical Studies

Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma

YOICHI HAMAI, MANABU EMI, YUTA IBUKI, YUJI MURAKAMI, IKUNO NISHIBUCHI, YASUSHI NAGATA, TAKAOKI FURUKAWA, TOMOAKI KUROKAWA, MANATO OHSAWA and MORIHITO OKADA
Anticancer Research March 2019, 39 (3) 1433-1440; DOI: https://doi.org/10.21873/anticanres.13259

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    Recurrence-free (RFS; left panel) and overall (OS; right panel) survival of patients with esophageal squamous cell carcinoma after trimodal therapy according to the presence of risk factors [pathological nodal staging (ypN), postoperative complications, and venous invasion] associated with early recurrence and early cancer death. A: Survival rates of patients according to ypN as a risk factor for early recurrence (p<0.0001). B: Survival rates of patients with Clavien–Dindo grade ≥3b postoperative complications with/without venous invasion compared with those with neither of them as risk factors for early cancer death (RFS: p=0.0004; OS: p=0.001).

Tables

  • Table I.
  • Table II.
  • Table III.
  • Table IV.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma
YOICHI HAMAI, MANABU EMI, YUTA IBUKI, YUJI MURAKAMI, IKUNO NISHIBUCHI, YASUSHI NAGATA, TAKAOKI FURUKAWA, TOMOAKI KUROKAWA, MANATO OHSAWA, MORIHITO OKADA
Anticancer Research Mar 2019, 39 (3) 1433-1440; DOI: 10.21873/anticanres.13259
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords